A new collaboration brokered by the Digital Medicine Society (DiMe) aims to help regulate digital health solutions in the United States.
The new partnership brokered by DiMe, an industry group, will bring representatives from the public and private sectors and industry associations together to inform future digital health regulatory strategies.
Joining the DiME on this project are Google, pharma giants Abbott, Amgen, Genentech and Janssen, the Consumer Technology Association (CTA), the U.S. Food and Drug Administration (FDA), the Harvard-MIT Center for Regulatory Science, and digital health company, Sidekick Health.